CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $64,039
- in 7 filings, $7K under 10b5-1 plans
Net −$64,039. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Lee Kevin −$27K CHIEF EXECUTIVE OFFICER sold 1% of stake
- Swanton Robert Charles −$12K Director sold 18% of stake
- Skynner Michael −$9K CHIEF SCIENTIFIC OFFICER sold 2% of stake
- Perry Jennifer Scott −$7K Chief Operating Officer sold 2% of stake
- Hannay Michael Charles Ferguson −$6K CHIEF PROD & SUPPLY CHAIN OFF sold 2% of stake
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-02 | Young Alethia Chief Financial Officer | Grant or award | +12,000 | 12,000 | ||
| 2024-01-02 | Young Alethia Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +24,000 | 24,000 | ||
| 2024-01-02 | Milnes Alistair Chief Operating Officer | Grant or award | +39,000 | 75,839 | ||
| 2024-01-02 | Milnes Alistair Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +77,000 | 77,000 | ||
| 2024-01-02 | Skynner Michael Chief Technology Officer | Grant or award | +28,000 | 98,482 | ||
| 2024-01-02 | Skynner Michael Chief Technology Officer | Grant or award · Employee Stock Option (right to buy) | +56,000 | 56,000 | ||
| 2024-01-02 | Lee Kevin Chief Executive Officer | Grant or award | +77,000 | 399,131 | ||
| 2024-01-02 | Lee Kevin Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +155,000 | 155,000 | ||
| 2023-10-03 | Thompson Travis Alvin Chief Accounting Officer | Sale | −54 | $20.00 | $1K | 7,979 |
| 2023-10-03 | Keen Nicholas Chief Scientific Officer | Sale | −272 | $20.00 | $5K | 38,233 |
| 2023-10-03 | Crockett Nigel Chief Business Officer | Sale | −442 | $20.00 | $9K | 29,359 |
| 2023-10-03 | Milnes Alistair Chief Operating Officer | Sale | −442 | $20.00 | $9K | 36,839 |
| 2023-10-03 | Lee Kevin Chief Executive Officer | Sale | −1,470 | $20.00 | $29K | 322,131 |
| 2023-10-03 | Skynner Michael Chief Technology Officer | Sale | −442 | $20.00 | $9K | 70,482 |
| 2023-07-17 | Young Alethia Chief Financial Officer | Grant or award · Employee Share Option (Right to Buy) | +120,000 | 120,000 | ||
| 2023-07-03 | Thompson Travis Alvin Chief Accounting Officer | Sale | −61 | $25.10 | $2K | 8,033 |
| 2023-07-03 | Skynner Michael Chief Technology Officer | Sale | −451 | $25.10 | $11K | 70,924 |
| 2023-07-03 | Milnes Alistair Chief Operating Officer | Sale | −451 | $25.10 | $11K | 37,281 |
| 2023-07-03 | Lee Kevin Chief Executive Officer | Sale | −1,498 | $25.10 | $38K | 323,601 |
| 2023-07-03 | Keen Nicholas Chief Scientific Officer | Sale | −336 | $25.10 | $8K | 38,505 |
Page 14 of 26 · 520 trades